Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance Study to Observe Safety and Effectiveness of BOSULIF

NCT06297161 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06297161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06297161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance Study to Observe Safety and Effectiveness of BOSULIF
Lead sponsor
Pfizer
Phase
Observational
Overall status
Recruiting
Start date
January 20, 2025
Completion date
June 1, 2028
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic leukemia myelogenous